Breast cancer consists of four molecular subtypes, including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC) [1–3]. This evidence concerns the gene ERBB2 and breast carcinoma.